FierceBiotech 2026-02-09 Lilly, Innovent pen $8.8B oncology, immunology collab that 'moves beyond traditional licensing'
FierceBiotech 2026-02-09 CSL signs on to $328M research collab with option for Memo’s immunoglobulin antibody tech
FierceBiotech 2026-02-09 The Data Multiplier Effect: When Expertise, Monitoring, Systems, and AI Align
FierceBiotech 2026-02-06 UniQure pauses Fabry gene therapy dosing in 2 groups after toxicities emerge
FierceBiotech 2026-02-06 Pfizer-backed Priovant scores again with fast-rising brepocitinib in midstage study
FierceBiotech 2026-02-06 Qiagen 'open for discussion' on shareholder value, but CEO stays mum on takeover talk
FierceBiotech 2026-02-05 Racing BMS and J&J, Bayer links asundexian to 26% stroke reduction to unblock path to FDA
FierceBiotech 2026-02-05 GE HealthCare posts higher full-year revenues amid turbulent tariff backdrop